These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 18430797)

  • 1. Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice.
    Mukhopadhaya A; Hanafusa T; Jarchum I; Chen YG; Iwai Y; Serreze DV; Steinman RM; Tarbell KV; DiLorenzo TP
    Proc Natl Acad Sci U S A; 2008 Apr; 105(17):6374-9. PubMed ID: 18430797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DEC-205-mediated antigen targeting to steady-state dendritic cells induces deletion of diabetogenic CD8⁺ T cells independently of PD-1 and PD-L1.
    Mukherjee G; Geliebter A; Babad J; Santamaria P; Serreze DV; Freeman GJ; Tarbell KV; Sharpe A; DiLorenzo TP
    Int Immunol; 2013 Nov; 25(11):651-60. PubMed ID: 24021877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
    Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM
    J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8+ dendritic cell-mediated tolerance of autoreactive CD4+ T cells is deficient in NOD mice and can be corrected by blocking CD40L.
    Price JD; Beauchamp NM; Rahir G; Zhao Y; Rieger CC; Lau-Kilby AW; Tarbell KV
    J Leukoc Biol; 2014 Feb; 95(2):325-36. PubMed ID: 24082013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Characterization of a Preclinical Model for the Evaluation of CD205-Mediated Antigen Delivery Therapeutics in Type 1 Diabetes.
    Schloss J; Ali R; Babad J; Guerrero-Ros I; Pongsachai J; He LZ; Keler T; DiLorenzo TP
    Immunohorizons; 2019 Jun; 3(6):236-253. PubMed ID: 31356169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell-targeted pancreatic beta-cell antigen leads to conversion of self-reactive CD4(+) T cells into regulatory T cells and promotes immunotolerance in NOD mice.
    Petzold C; Riewaldt J; Koenig T; Schallenberg S; Kretschmer K
    Rev Diabet Stud; 2010; 7(1):47-61. PubMed ID: 20703438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting DEC-205
    Tabansky I; Keskin DB; Watts D; Petzold C; Funaro M; Sands W; Wright P; Yunis EJ; Najjar S; Diamond B; Cao Y; Mooney D; Kretschmer K; Stern JNH
    Mol Med; 2018 May; 24(1):17. PubMed ID: 30134798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DCIR2+ cDC2 DCs and Zbtb32 Restore CD4+ T-Cell Tolerance and Inhibit Diabetes.
    Price JD; Hotta-Iwamura C; Zhao Y; Beauchamp NM; Tarbell KV
    Diabetes; 2015 Oct; 64(10):3521-31. PubMed ID: 26070317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting dendritic cells in humanized mice receiving adoptive T cells via monoclonal antibodies fused to Flu epitopes.
    Graham JP; Authie P; Yu CI; Zurawski SM; Li XH; Marches F; Flamar AL; Acharya A; Banchereau J; Palucka AK
    Vaccine; 2016 Sep; 34(41):4857-4865. PubMed ID: 27595442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination.
    Bonifaz LC; Bonnyay DP; Charalambous A; Darguste DI; Fujii S; Soares H; Brimnes MK; Moltedo B; Moran TM; Steinman RM
    J Exp Med; 2004 Mar; 199(6):815-24. PubMed ID: 15024047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic identification of MHC class I-associated peptidome derived from non-obese diabetic mouse thymus and pancreas.
    Wang L; Li X; Yang S; Chen X; Li J; Wang S; Zhang M; Zheng Z; Zhou J; Wang L; Wu Y
    J Proteomics; 2023 Jan; 270():104746. PubMed ID: 36210013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mimovirus encoding ChgA
    Sun H; Han X; Yan X; Xu J; Huang Q; Meng F; Zhang H; Li S
    Cell Immunol; 2017 Oct; 320():56-61. PubMed ID: 28916112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: merocytic dendritic cells break T cell tolerance to beta cell antigens in nonobese diabetic mouse diabetes.
    Katz JD; Ondr JK; Opoka RJ; Garcia Z; Janssen EM
    J Immunol; 2010 Aug; 185(4):1999-2003. PubMed ID: 20644171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breaking T cell tolerance to beta cell antigens by merocytic dendritic cells.
    Katz JD; Janssen EM
    Cell Mol Life Sci; 2011 Sep; 68(17):2873-83. PubMed ID: 21626409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopeptidome mining reveals a novel ERS-induced target in T1D.
    Wang L; Yang S; Zhu G; Li J; Meng G; Chen X; Zhang M; Wang S; Li X; Pan Y; Huang Y; Wang L; Wu Y
    Cell Mol Immunol; 2024 Jun; 21(6):604-619. PubMed ID: 38689020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo.
    Hawiger D; Inaba K; Dorsett Y; Guo M; Mahnke K; Rivera M; Ravetch JV; Steinman RM; Nussenzweig MC
    J Exp Med; 2001 Sep; 194(6):769-79. PubMed ID: 11560993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTPN2 restrains CD8⁺ T cell responses after antigen cross-presentation for the maintenance of peripheral tolerance in mice.
    Wiede F; Ziegler A; Zehn D; Tiganis T
    J Autoimmun; 2014 Sep; 53():105-14. PubMed ID: 24997008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual nonobese diabetic mice exhibit unique patterns of CD8+ T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase.
    Lieberman SM; Takaki T; Han B; Santamaria P; Serreze DV; DiLorenzo TP
    J Immunol; 2004 Dec; 173(11):6727-34. PubMed ID: 15557165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes.
    Marin-Gallen S; Clemente-Casares X; Planas R; Pujol-Autonell I; Carrascal J; Carrillo J; Ampudia R; Verdaguer J; Pujol-Borrell R; Borràs FE; Vives-Pi M
    Clin Exp Immunol; 2010 May; 160(2):207-14. PubMed ID: 20030670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.
    Gaudreau S; Guindi C; Ménard M; Besin G; Dupuis G; Amrani A
    J Immunol; 2007 Sep; 179(6):3638-47. PubMed ID: 17785799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.